Verano Holdings Tuesday Midday Brief: Illinois Anchor and Premium Brands Define Q2 2026 Earnings Thesis
TL;DR: Verano Holdings (OTC: VRNOF) approaches its Q2 2026 earnings report as one of the most operationally focused midsize multi-state operators in the U.S. cannabis sector, with Illinois remaining its highest-volume market and a tiered brand portfolio commanding above-average basket sizes in core states. Investors will be watching for margin stability and free cash flow […]
Verano Holdings Tuesday Midday Brief: Illinois Anchor and Premium Brands Define Q2 2026 Earnings Thesis
TL;DR: Verano Holdings (OTC: VRNOF) approaches its Q2 2026 earnings report as one of the most operationally focused midsize multi-state operators in the U.S. cannabis sector, with Illinois remaining its highest-volume market and a tiered brand portfolio commanding above-average basket sizes in core states. Investors will be watching for margin stability and free cash flow […]
Cannabis Schedule III Rescheduling: DEA Final Rule Timeline and 280E Relief Mechanics as Q2 2026 Concludes
TL;DR: The cannabis sector closes Q2 2026 with Schedule III rescheduling still in DEA administrative adjudication, but multiple structural indicators suggest a final rule publication in the second half of the year remains achievable. The 280E tax relief that would follow rescheduling — estimated at hundreds of millions in aggregate annual tax savings across profitable […]
Organigram Holdings Tuesday Brief: BAT Partnership and International Medical Sales Define Canadian LP Thesis Into Q3 2026
TL;DR: Organigram Holdings (NASDAQ: OGI; TSX: OGI) closes Q2 2026 with a differentiated Canadian LP profile anchored by its BAT-backed research program and expanding international medical revenue. As the sector awaits DEA finalization of Schedule III rescheduling, OGI’s capital-light growth strategy and cross-border positioning offer institutional investors a distinct risk-reward profile relative to U.S. MSO […]
Cannabis Sector Q2 2026 Close: Key Metrics and Earnings Catalysts to Monitor as MSOs Book the Quarter
TL;DR: Cannabis equities are entering the final trading session of Q2 2026 on Tuesday with major multi-state operators stabilized near multi-quarter highs, underpinned by persistent rescheduling momentum and the prospect of 280E tax relief materializing in reported financials. Institutional positioning ahead of Q2 earnings — expected in August — will be the primary driver of […]
Trulieve Cannabis Monday Brief: Florida Market Leadership and 280E Relief Position Southeast MSO for Q3 2026 Inflection
TL;DR: Trulieve Cannabis (TCNNF) enters Q3 2026 as Florida’s dominant cannabis operator, with the state’s adult-use market expansion representing the most significant near-term volume catalyst for a company whose vertically integrated footprint was built expressly for the Florida regulatory environment. The approaching resolution of the Section 280E federal tax burden under Schedule III rescheduling represents […]
Cannabis Sector Monday Market Open: Q2 2026 Close Positions Major MSOs for Regulatory-Driven Q3 Catalyst Window
TL;DR: Cannabis equities close out Q2 2026 with sector-wide momentum building around the DEA’s Schedule III rescheduling rulemaking and renewed congressional support for the SAFER Banking Act, setting up major MSOs for a potential Q3 inflection. The removal of the Section 280E federal tax burden — the single most consequential near-term financial catalyst for plant-touching […]
AYR Wellness Sunday Close: Florida Recreational Momentum and 280E Relief Position Multi-State Operator for H2 2026 Recovery
TL;DR: AYR Wellness (OTC: AYRWF) enters the second half of 2026 with its largest market generating meaningful recreational cannabis revenue, a structural 280E cost tailwind from April’s federal medical rescheduling, and a deleveraging balance sheet that has materially improved operator visibility. With DEA adult-use rescheduling hearings approaching a record close, AYR sits at an inflection […]
Cresco Labs Sunday Afternoon MSO Analysis: Wholesale Distribution Model and CPG Strategy Offer Differentiated Rescheduling Upside
TL;DR: Cresco Labs (OTC: CRLBF) trades at a discount to its larger MSO peers, but the company’s wholesale distribution infrastructure and consumer packaged goods brand strategy — anchored by the High Supply, FloraCal, and Mindy’s brands — represent a structural advantage that becomes more pronounced as cannabis approaches federal normalization. Sunday’s afternoon session highlights CRLBF’s […]
Green Thumb Industries Sunday Midday Review: Dense Retail Network and Conservative Balance Sheet Define the Premier MSO Case
TL;DR: Green Thumb Industries (OTC: GTBIF) enters the final stretch of cannabis rescheduling proceedings as one of the sector’s most financially disciplined multi-state operators, with over 70 RISE dispensary locations, minimal debt, and an estimated $40–55 million annual 280E tax relief windfall at stake. Sunday’s midday session finds GTBIF holding near multi-year technical highs alongside […]